STOCK TITAN

Repare Therapeutics Inc. (RPTX) Net Income by Year

RPTX

Repare Therapeutics Inc. reported a net loss of $84.7M in fiscal year 2024. This represents an increase of 9.7% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Repare Therapeutics Inc. has filed alongside them.

FY2024 annual
Net Income -$84.7M
YoY +9.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RPTX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$84.7M+9.7%-$93.8M-222.9%-$29.0M+72.8%-$106.9M-100.1%-$53.4M-96.3%-$27.2M

RPTX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Net Income$3.3M+109.5%-$16.7M+51.8%-$30.0M-328.3%N/A-$34.4M-82.2%-$34.8M-191.1%$13.2M+137.7%N/A-$18.9M-125.0%-$11.9M+68.6%-$34.9M-0.5%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Repare Therapeutics Inc. financials

Frequently Asked Questions

What was Repare Therapeutics Inc.'s net income in fiscal year 2024?

Repare Therapeutics Inc. reported a net loss of $84.7M in fiscal year 2024.

How fast is Repare Therapeutics Inc.'s net income growing?

Repare Therapeutics Inc. (RPTX) net income rose by 9.7% year over year, from -$93.8M to -$84.7M in fiscal year 2024.

How has Repare Therapeutics Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Repare Therapeutics Inc. (RPTX) net income went from -$27.2M in fiscal year 2019 to -$84.7M in fiscal year 2024.

Repare Therapeutics Inc. (RPTX) reported $3.3M in net income in Q3 2025. This represents an increase of 109.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Repare Therapeutics Inc. (RPTX) reported on that line in every period on record.